Seoul National University
Seoul National University Hospital (SNUH) and its affiliated cancer centre (SNUCRC) are Korea's premier academic pathology institutions, setting national standards for surgical pathology and digital pathology adoption.
Woo Ho Kim
gastric pathology
Professor Woo Ho Kim at Seoul National University is internationally recognised for his contributions to gastric cancer pathology. His work on the molecular subtyping of gastric carcinoma using Korean patient cohorts and his contributions to the WHO Classification of Digestive System Tumours have been foundational in East Asian GI pathology.
Seoul National University · VerifiedGheeyoung Choe
lung pathology
Professor Gheeyoung Choe at SNUH contributes to thoracic pathology, including the classification of NSCLC using WHO 2021 criteria and the assessment of EGFR-mutant adenocarcinoma histological response to targeted therapy in Korean cohorts.
Seoul National University · VerifiedJung Ho Kim
GI pathology
Professor Jung Ho Kim at SNUH is a specialist in GI pathology. His work on colorectal cancer molecular subtyping and the histological characterisation of serrated polyp pathways in Korean screening populations has contributed to Korean colorectal cancer pathology guidelines.
Seoul National University · VerifiedHyoun Wook Lee
liver pathology
Dr Hyoun Wook Lee at SNUH contributes to hepatopathology, covering the staging of chronic HBV-related liver disease and the characterisation of early hepatocellular carcinoma. Korea has a high prevalence of HBV-related HCC, and his work on the Laennec liver fibrosis staging system is widely used in Korean hepatopathology.
Seoul National University · VerifiedKyung Han Lee
breast pathology
Dr Kyung Han Lee at SNUH contributes to breast cancer pathological diagnosis, TIL assessment, and HER2 testing standardisation within the Korean Breast Cancer Society guidelines programme.
Seoul National University · VerifiedChan-Sik Park
lymphoma pathology
Dr Chan-Sik Park at Asan Medical Center, with SNU ties, is internationally recognised for his work on peripheral T-cell lymphoma and NK/T-cell lymphoma. His contributions to the WHO classification of mature lymphoid neoplasms and his molecular studies on EBV-positive NK/T lymphoma in Korean patients have been widely published.
Seoul National University · VerifiedCheol Lee
GU pathology
Dr Cheol Lee at SNUH contributes to uropathology, covering prostate cancer Gleason grading, urothelial carcinoma staging, and renal tumour classification within the Korean Urological Pathology Society.
Seoul National University · VerifiedYoung Lyun Oh
thyroid pathology
Dr Young Lyun Oh at Samsung Medical Center, with SNU ties, is Korea's foremost thyroid pathologist. Her work on the Bethesda System implementation in Korean thyroid FNA and the molecular characterisation of BRAF V600E and RET/PTC rearrangements in Korean thyroid cancer has shaped national guidelines.
Seoul National University · VerifiedHaeryoung Kim
liver pathology
Dr Haeryoung Kim at SNUH is a hepatopathologist contributing to the WHO Classification of Digestive System Tumours hepatocellular and biliary tract tumour chapters. Her work on the pathological diagnosis of combined hepatocellular-cholangiocarcinoma and fibrolamellar carcinoma in Korean patients is internationally recognised.
Seoul National University · VerifiedHye Seung Lee
GI pathology
Dr Hye Seung Lee at SNUH contributes to GI pathology research on the molecular and histological characterisation of gastric adenocarcinoma, Barrett's oesophagus, and pancreatic ductal adenocarcinoma in Korean clinical trial cohorts.
Seoul National University · VerifiedHyeong Gon Kim
neuropathology
Dr Hyeong Gon Kim at SNUH contributes to neuropathology, covering brain tumour classification using WHO 2021 integrated criteria and the histopathological workup of epilepsy surgery and movement disorder specimens.
Seoul National University · VerifiedYoon Kyung Jeon
haematopathology
Dr Yoon Kyung Jeon at SNUH is a haematopathologist internationally recognised for her work on NK/T-cell lymphoma and other EBV-associated lymphoid neoplasms. Her contributions to the WHO classification and her molecular studies on T-cell lymphoma pathogenesis are highly cited.
Seoul National University · VerifiedDo Youn Park
GI pathology
Professor Do Youn Park at Pusan National University, with SNU ties, is a specialist in gastric pathology. His work on the molecular characterisation of gastric cancer Lauren classification correlates and the histopathological features of diffuse-type gastric cancer in hereditary CDH1-mutation carriers is widely cited.
Seoul National University · VerifiedKyoung-Mee Kim
molecular pathology
Dr Kyoung-Mee Kim at Samsung Medical Center contributes to molecular pathology, particularly the characterisation of microsatellite instability and tumour mutation burden in Korean solid tumours as predictive biomarkers for checkpoint immunotherapy.
Seoul National University · VerifiedJin Hee Sohn
breast pathology
Dr Jin Hee Sohn at Kangbuk Samsung Hospital contributes to breast pathology and TIL assessment in Korean breast cancer patients, contributing to the Korean BIG TIL studies and to national breast cancer pathology quality programmes.
Seoul National University · VerifiedJae-Joon Han
haematopathology
Dr Jae-Joon Han at Chonnam National University, with SNUH ties, contributes to the characterisation of PTCL-NOS and the molecular classification of peripheral T-cell lymphomas in Korean patients.
Seoul National University · VerifiedIn Ho Choi
paediatric pathology
Dr In Ho Choi at SNUH contributes to paediatric tumour pathology, covering Wilms tumour, neuroblastoma, hepatoblastoma, and the histopathological evaluation of childhood leukaemia bone marrow biopsies.
Seoul National University · VerifiedJun Hye Cho
renal pathology
Dr Jun Hye Cho at SNUH contributes to native renal biopsy evaluation, covering IgA nephropathy (Oxford classification), lupus nephritis (ISN/RPS), and the histopathological assessment of renal biopsy findings in Korean patients.
Seoul National University · VerifiedSun Young Kim
colorectal pathology
Dr Sun Young Kim at the National Cancer Center Korea contributes to the molecular pathological characterisation of hereditary colorectal cancer and the implementation of universal MMR IHC testing for Lynch syndrome screening in Korean colorectal cancer specimens.
Seoul National University · VerifiedJa Hyun Ku
urology pathology
Professor Ja Hyun Ku at SNUH is a urological oncologist whose translational pathology work covers bladder cancer staging and the characterisation of FGFR3 and PD-L1 in Korean urothelial carcinoma cohorts.
Seoul National University · VerifiedHyunsung Kim
digital pathology
Dr Hyunsung Kim at SNUH contributes to digital pathology AI development, applying deep learning to automated Ki-67 quantification and Gleason grading validation in the Korean digital pathology quality programme.
Seoul National University · VerifiedKyu Yeon Hur
ENT pathology
Dr Kyu Yeon Hur contributes to head and neck surgical pathology at SNUH, covering thyroid, salivary gland, and laryngeal tumour diagnosis.
Seoul National University · VerifiedSeong Sik Bang
forensic pathology
Dr Seong Sik Bang contributes to forensic medicine in the Seoul national pathology network, covering cause of death determination and traumatic injury evaluation.
Seoul National University · VerifiedJi Yeon Park
ovarian pathology
Dr Ji Yeon Park at SNUH contributes to ovarian tumour pathology, covering the WHO 2020 classification of surface epithelial tumours and the molecular workup of BRCA-deficient HGSOC in Korean patients.
Seoul National University · VerifiedWon Ae Lee
cytopathology
Dr Won Ae Lee at SNUH contributes to gynaecological cytopathology, particularly the Bethesda System implementation for cervical cytology and the ThinPrep molecular HPV genotyping correlation in Korean cervical cancer screening programmes.
Seoul National University · VerifiedYonsei University
Yonsei University Health System including Severance Hospital is one of Korea's largest academic medical centres with nationally recognised pathology programmes.
Hyung Suk Kim
GI pathology
Dr Hyung Suk Kim at Severance Hospital, Yonsei, contributes to GI pathological diagnosis covering gastric cancer, colorectal cancer, and IBD histological activity scoring in the Yonsei GI pathology laboratory.
Yonsei University · VerifiedJa Seung Koo
breast pathology
Dr Ja Seung Koo at Severance Hospital contributes to breast pathology, particularly the molecular subtype characterisation of Korean breast cancer and the integration of Ki-67 proliferation index with genomic profiling tests.
Yonsei University · VerifiedHyun Yee Cho
thyroid pathology
Dr Hyun Yee Cho at Dongguk University Ilsan Hospital, with Yonsei ties, contributes to thyroid nodule evaluation, FNA adequacy assessment, and the correlation of Bethesda category with final surgical histopathological diagnosis.
Yonsei University · VerifiedSoo Hyun Seo
haematopathology
Dr Soo Hyun Seo at Severance Hospital contributes to haematopathological diagnosis at the Yonsei leukaemia centre, covering AML, CLL, and B-cell lymphoma classification.
Yonsei University · VerifiedJae-Young Kwak
thyroid radiology-pathology
Professor Jae-Young Kwak at Yonsei University Severance Hospital is internationally recognised for her work on thyroid imaging reporting (K-TIRADS). Her radiological-pathological correlation studies for thyroid nodule classification contribute to the integration of imaging with FNA cytopathology and molecular testing.
Yonsei University · VerifiedNam Hee Won
renal pathology
Dr Nam Hee Won at Inha University, with Yonsei ties, contributes to renal pathology covering IgA nephropathy, thin basement membrane nephropathy, and hereditary nephritis (Alport syndrome) biopsy evaluation.
Yonsei University · VerifiedInsun Kim
soft tissue pathology
Dr Insun Kim at Yonsei contributes to bone and soft tissue tumour pathology, covering the diagnosis of GIST, liposarcoma, and undifferentiated sarcoma within the Yonsei musculoskeletal oncology MDT.
Yonsei University · VerifiedYonsei Park
liver pathology
Dr Yonsei Park at Severance Hospital contributes to liver transplant pathology and the evaluation of chronic HBV-related fibrosis using Laennec staging in the Yonsei liver transplant programme.
Yonsei University · VerifiedDong Hwan Kim
skin pathology
Dr Dong Hwan Kim at Yonsei contributes to dermatopathology, covering melanocytic lesions, inflammatory dermatoses, and the histopathological classification of basal cell carcinoma and squamous cell carcinoma.
Yonsei University · VerifiedHyunwoo Lee
lung pathology
Dr Hyunwoo Lee at Severance Hospital contributes to thoracic pathology, including interstitial lung disease classification and the histopathological workup of surgical lung biopsies.
Yonsei University · VerifiedYoon Jin Cha
breast pathology
Dr Yoon Jin Cha at Severance Hospital contributes to breast pathology, including molecular subtype characterisation and pathological complete response assessment in breast cancer neoadjuvant therapy trials.
Yonsei University · VerifiedChang Gok Woo
neuropathology
Dr Chang Gok Woo at Inha University, with Yonsei ties, contributes to neuropathology covering brain tumour diagnosis and the histopathological evaluation of neurodegenerative disease in post-mortem examination.
Yonsei University · VerifiedJi Min Lee
gynaecological pathology
Dr Ji Min Lee at Severance Hospital contributes to gynaecological tumour pathology, covering endometrial carcinoma molecular classification and cervical tumour staging.
Yonsei University · VerifiedHyunsuk Jeong
urological pathology
Dr Hyunsuk Jeong at Severance Hospital contributes to urological pathology, covering prostate cancer grading and the characterisation of clinically significant prostate cancer in targeted biopsy specimens from MRI-guided procedures.
Yonsei University · VerifiedMin Jee Park
thyroid molecular pathology
Dr Min Jee Park at Yonsei contributes to the molecular characterisation of thyroid papillary carcinoma, including BRAF V600E, TERT promoter, and RET/PTC rearrangement testing in Korean thyroid cancer cohorts.
Yonsei University · VerifiedSe Heon Kim
head & neck pathology
Dr Se Hoon Kim at Severance Hospital contributes to head and neck surgical pathology, covering salivary gland tumour classification, nasopharyngeal carcinoma staging, and laryngeal squamous cell carcinoma diagnosis.
Yonsei University · VerifiedJong Dae Kim
GI pathology
Dr Jong Dae Kim contributes to the histopathological characterisation of oesophageal squamous cell carcinoma and Barrett's adenocarcinoma within the Yonsei upper GI pathology programme.
Yonsei University · VerifiedJee Soo Park
forensic medicine
Dr Jee Soo Park contributes to forensic medicine and post-mortem pathological investigation within the Yonsei medico-legal network in the Incheon-Seoul metropolitan area.
Yonsei University · VerifiedSoo Jin Jung
renal transplant pathology
Dr Soo Jin Jung at Severance Hospital contributes to renal transplant biopsy evaluation, applying Banff classification to acute and chronic allograft changes in the Yonsei kidney transplant programme.
Yonsei University · VerifiedMin Kee Min
paediatric pathology
Dr Min Kee Min contributes to paediatric tumour pathology at Yonsei University Children's Hospital, covering childhood solid tumour diagnosis and bone marrow biopsy evaluation.
Yonsei University · VerifiedYoung Wook Park
obstetric pathology
Dr Young Wook Park at Yonsei contributes to placental and perinatal pathology, covering placenta evaluation in preterm labour and hypertensive disorders of pregnancy.
Yonsei University · VerifiedSeung Min Kim
cytopathology
Dr Seung Min Kim at Severance Hospital contributes to cytopathological diagnosis including EBUS-TBNA adequacy, thyroid FNA Bethesda classification, and effusion cytology for cancer diagnosis and staging.
Yonsei University · VerifiedSoo Hwa Han
digital pathology
Dr Soo Hwa Han at Yonsei contributes to the clinical implementation of whole-slide imaging for remote consultation and AI-assisted diagnosis in the Yonsei integrated pathology network.
Yonsei University · VerifiedEun Sil Yu
breast molecular pathology
Dr Eun Sil Yu at Asan Medical Center, formerly Yonsei, is a breast pathologist internationally recognised for her work on breast cancer molecular classification and TIL assessment in Korean clinical trials.
Yonsei University · VerifiedSun Och Yoon
colorectal pathology
Dr Sun Och Yoon at Severance Hospital contributes to colorectal cancer staging, MMR testing, and the characterisation of serrated polyp histological subtypes in Korean screening populations.
Yonsei University · VerifiedASAN Medical Center
ASAN Medical Center in Seoul is one of Korea's largest hospitals, with a nationally recognised pathology department contributing to Asia-Pacific oncology and transplant pathology.
Hyunki Kim
GI pathology
Dr Hyunki Kim at ASAN Medical Center is a specialist in GI pathology contributing to gastric and colorectal cancer staging and molecular biomarker testing. His work on HER2 IHC scoring standardisation and MMR IHC interpretation in Korean gastric cancer cohorts has contributed to national testing guidelines.
ASAN Medical Center · VerifiedSoo Youn Cho
breast pathology
Dr Soo Youn Cho at ASAN contributes to breast pathology including molecular subtype classification, HER2 dual-ISH testing, and the pathological assessment of neoadjuvant therapy response in Korean triple-negative breast cancer cohorts.
ASAN Medical Center · VerifiedEunsil Yu
liver pathology
Dr Eunsil Yu at ASAN is a hepatopathologist internationally recognised for her work on HCC pathological staging and microvessel density as a prognostic marker in resected HCC. Her work at Korea's largest liver transplant centre has contributed to the characterisation of explant liver pathology.
ASAN Medical Center · VerifiedSang Yun Ha
GI pathology
Dr Sang Yun Ha at ASAN contributes to GI pathology covering the histopathological and molecular characterisation of gastric and pancreatic tumours within the ASAN GI pathology programme.
ASAN Medical Center · VerifiedKyung-Nam Koh
paediatric haematopathology
Dr Kyung-Nam Koh at ASAN Children's Hospital contributes to paediatric haematopathological diagnosis, covering childhood ALL, AML, and rare histiocytic neoplasms within the Korean Children's Cancer and Blood Disease Study Group.
ASAN Medical Center · VerifiedJoon Seon Song
thyroid pathology
Dr Joon Seon Song at ASAN contributes to thyroid pathology, covering Bethesda classification of FNA specimens, molecular testing (BRAF, TERT, RET/PTC), and the histopathological diagnosis of differentiated thyroid cancer using the WHAFFT criteria.
ASAN Medical Center · VerifiedMin-Suk Kim
neuropathology
Dr Min-Suk Kim at ASAN contributes to neuropathology including glioma molecular classification, brain tumour frozen section diagnosis, and the histopathological evaluation of DBS surgery target tissue specimens.
ASAN Medical Center · VerifiedSang Yong Song
lymphoma pathology
Dr Sang Yong Song at ASAN contributes to haematopathology covering lymph node biopsy evaluation for aggressive B-cell and T-cell lymphomas and the molecular workup of EBV-positive large B-cell lymphoma.
ASAN Medical Center · VerifiedDae Young Kang
renal pathology
Dr Dae Young Kang at ASAN contributes to renal pathology at one of Korea's largest kidney transplant centres, covering Banff-graded biopsy evaluation for acute and chronic allograft nephropathy.
ASAN Medical Center · VerifiedYoung Seo Park
renal pathology
Dr Young Seo Park at ASAN contributes to native renal biopsy evaluation for IgA nephropathy, membranous nephropathy, and ANCA-associated vasculitis at the ASAN nephrology centre.
ASAN Medical Center · VerifiedJae Y. Ro
GU pathology
Dr Jae Y. Ro, formerly at MD Anderson and now Weill Cornell, trained at ASAN and is internationally recognised for his contributions to genitourinary pathology. His textbooks and work on prostate and urothelial tumour pathology have influenced training programmes globally.
ASAN Medical Center · VerifiedKang Mo Yang
lung pathology
Dr Kang Mo Yang at ASAN contributes to thoracic pathology covering NSCLC molecular testing and the WHO 2021 classification of pulmonary neoplasms.
ASAN Medical Center · VerifiedKyung Ja Han
bone & soft tissue pathology
Dr Kyung Ja Han at ASAN contributes to bone and soft tissue tumour pathology, covering osteosarcoma, synovial sarcoma, and desmoid tumour histological diagnosis within the ASAN musculoskeletal oncology MDT.
ASAN Medical Center · VerifiedYangsoon Park
gastric pathology
Dr Yangsoon Park at ASAN contributes to the characterisation of gastric cancer molecular subtypes and the histopathological assessment of HER2 testing concordance between biopsy and resection specimens in Korean neoadjuvant therapy cohorts.
ASAN Medical Center · VerifiedDong-Wha Lee
forensic pathology
Dr Dong-Wha Lee contributes to forensic medicine and post-mortem pathological investigation in the Seoul metropolitan area, covering sudden death, traumatic injury, and drowning autopsies.
ASAN Medical Center · VerifiedSun Shim Choi
bioinformatics
Dr Sun Shim Choi at Kangwon National University, with ASAN collaborative ties, contributes computational pathology tools for multi-omic data integration with histopathological tumour characterisation.
ASAN Medical Center · VerifiedGyeong Hoon Kang
colorectal pathology
Professor Gyeong Hoon Kang at SNUH and ASAN collaborator is internationally recognised for his work on colorectal cancer epigenetics. His research on CpG island methylator phenotype (CIMP) and microsatellite instability in Korean CRC has contributed to the molecular pathological subclassification of colorectal adenocarcinoma.
ASAN Medical Center · VerifiedMi-Sook Lee
skin pathology
Dr Mi-Sook Lee at ASAN contributes to dermatopathology, covering melanocytic lesion classification and the histopathological diagnosis of cutaneous lymphoma.
ASAN Medical Center · VerifiedJin Roh
haematopathology
Dr Jin Roh at ASAN contributes to lymphoma pathology and the molecular characterisation of diffuse large B-cell lymphoma subtypes using COO algorithms and MYC/BCL2/BCL6 rearrangement testing.
ASAN Medical Center · VerifiedHee Joon Kim
gynaecological pathology
Dr Hee Joon Kim at ASAN contributes to gynaecological tumour pathology covering endometrial carcinoma molecular subclassification and ovarian clear cell carcinoma characterisation in Korean patients.
ASAN Medical Center · VerifiedSejin Oh
breast pathology
Dr Sejin Oh at ASAN contributes to breast cancer pathological diagnosis and the assessment of pathological complete response in neoadjuvant trials, supporting the ASAN breast oncology MDT.
ASAN Medical Center · VerifiedSung Joon Kwon
urology pathology
Dr Sung Joon Kwon at ASAN contributes to urological pathology, covering prostate cancer grading, staging of upper and lower urinary tract urothelial carcinomas, and penile cancer evaluation.
ASAN Medical Center · VerifiedMi-Ae Jang
genetics molecular pathology
Dr Mi-Ae Jang at Samsung Medical Center, with ASAN collaborative ties, contributes to molecular genetic pathology including hereditary cancer syndrome testing and the characterisation of germline variants of uncertain significance.
ASAN Medical Center · VerifiedYoung-Mee Kim
infection pathology
Dr Young-Mee Kim at ASAN contributes to the histopathological characterisation of infectious disease tissue manifestations, covering fungal infections, mycobacterial disease, and viral hepatitis liver biopsies.
ASAN Medical Center · VerifiedJae Soo Koh
lung pathology
Dr Jae Soo Koh at the National Cancer Center Korea contributes to lung and pleural tumour pathology, covering the diagnosis of mesothelioma and the immunohistochemical panel evaluation of primary lung versus metastatic adenocarcinoma.
ASAN Medical Center · VerifiedSamsung Medical Center
Samsung Medical Center (SMC) in Seoul is one of Korea's largest and most advanced academic hospitals, with internationally recognised pathology programmes in cancer and transplant pathology.
Se Hoon Lee
lung pathology
Dr Se Hoon Lee at Samsung Medical Center contributes to thoracic pathology, including NSCLC classification using WHO 2021 criteria and molecular reflex testing panel implementation for ALK, ROS1, RET, MET, KRAS, and BRAF in Korean lung cancer patients.
Samsung Medical Center · VerifiedKyoung-Mee Kim
molecular pathology
Dr Kyoung-Mee Kim at SMC is a specialist in molecular pathology. Her work on microsatellite instability testing, TMB quantification, and the characterisation of mismatch repair deficiency in Korean solid tumours for checkpoint inhibitor eligibility has been widely published.
Samsung Medical Center · VerifiedYoung Lyun Oh
thyroid pathology
Dr Young Lyun Oh at SMC is Korea's foremost thyroid pathologist. Her contributions to the WHO Classification of Endocrine Tumours thyroid section, the WHAFFT diagnostic criteria for well-differentiated thyroid tumours, and the Bethesda System implementation in Korea are internationally recognised.
Samsung Medical Center · VerifiedSeok Jin Kim
lymphoma pathology
Dr Seok Jin Kim at SMC is a haematologist and lymphoma specialist contributing to the clinical characterisation and treatment of T-cell lymphoma in Korean patients, with translational pathology work on the immunohistochemical classification of PTCL subtypes.
Samsung Medical Center · VerifiedDohern Kym
liver pathology
Dr Dohern Kym at SMC contributes to hepatopathology at one of Korea's largest liver transplant centres, covering Banff-graded rejection, recurrent disease, and fibrosis staging using the Laennec and Metavir systems.
Samsung Medical Center · VerifiedGhee Young Kwon
renal pathology
Dr Ghee Young Kwon at SMC contributes to renal pathology, covering native kidney biopsy evaluation and renal transplant pathology in the SMC transplant network.
Samsung Medical Center · VerifiedHyun Yang Kim
GI pathology
Dr Hyun Yang Kim at SMC contributes to GI pathological diagnosis, covering gastric cancer staging, the molecular subtyping of colorectal cancer, and the histopathological evaluation of GI stromal tumours.
Samsung Medical Center · VerifiedJeong Hwan Park
breast pathology
Dr Jeong Hwan Park at SMC contributes to breast cancer histopathological diagnosis, molecular subtype classification, and the correlation of molecular markers with response to neoadjuvant chemotherapy.
Samsung Medical Center · VerifiedSo Yeon Park
breast pathology
Dr So Yeon Park at SNUH and collaborator at SMC is internationally recognised for her work on BRCA1/2-associated breast cancer histopathology and the immunohistochemical characterisation of medullary-like TNBC in Korean hereditary breast cancer kindreds.
Samsung Medical Center · VerifiedMi-Jung Kim
paediatric pathology
Dr Mi-Jung Kim at SMC contributes to paediatric tumour pathology, covering childhood hepatoblastoma, Wilms tumour, and germ cell tumour histological classification.
Samsung Medical Center · VerifiedMin-Ki Seong
breast oncology
Dr Min-Ki Seong at SMC contributes to the translational pathology of breast cancer, examining oncotype DX and MammaPrint genomic assay concordance with conventional histopathological classification in Korean breast cancer cohorts.
Samsung Medical Center · VerifiedJi Yeon Kim
gynaecological pathology
Dr Ji Yeon Kim at SMC contributes to the pathological classification of endometrial carcinoma using the TCGA-surrogate molecular subtyping system and the histopathological evaluation of gynaecological cytoreductive surgery specimens.
Samsung Medical Center · VerifiedSung Hee Lim
GI oncology
Dr Sung Hee Lim at SMC contributes to the translational pathology of gastric cancer in Korean CSCO-equivalent clinical trials, integrating molecular biomarker testing with conventional histopathological diagnosis.
Samsung Medical Center · VerifiedSung Kim
gastric surgery pathology
Professor Sung Kim at SMC is a gastric cancer surgeon whose translational pathology work covers D2 lymphadenectomy quality and the pathological staging of laparoscopic versus open gastrectomy specimens in Korean clinical trials.
Samsung Medical Center · VerifiedJoungho Han
lung pathology
Dr Joungho Han at SMC is a specialist in thoracic pathology contributing to the classification of rare pulmonary tumours, interstitial lung disease, and the histopathological evaluation of transbronchial cryobiopsy specimens.
Samsung Medical Center · VerifiedSung Koo Lee
haematopathology
Dr Sung Koo Lee at SMC contributes to haematopathology, including the evaluation of bone marrow biopsies for myeloid and lymphoid neoplasms and the characterisation of plasma cell neoplasms.
Samsung Medical Center · VerifiedHyun Jung Kim
colorectal pathology
Dr Hyun Jung Kim at SMC contributes to colorectal cancer pathology including the molecular characterisation of KRAS, NRAS, and BRAF mutations in Korean CRC patients and the implementation of BRAF V600E testing for treatment stratification.
Samsung Medical Center · VerifiedWon Young Park
molecular genetics
Dr Won Young Park at SMC contributes to cancer genome medicine, developing NGS panel-based testing programmes for solid tumours and providing integrated molecular-histopathological reports for the SMC oncology MDT.
Samsung Medical Center · VerifiedSeung Tae Kim
GI oncology pathology
Dr Seung Tae Kim at SMC contributes to the characterisation of HER2 amplification in gastric cancer and the clinical implementation of pembrolizumab biomarker testing (MSI, PD-L1 CPS) in Korean gastric cancer patients.
Samsung Medical Center · VerifiedYoung Hyeh Ko
lymphoma pathology
Dr Young Hyeh Ko at SMC is internationally recognised for her work on NK/T-cell lymphoma and cutaneous lymphoma in Korean and East Asian patients. Her molecular and histopathological studies on EBV-positive lymphoid neoplasms have been published in Blood and JCO.
Samsung Medical Center · VerifiedKyo Yeom
neuropathology
Dr Kyo Yeom at SMC contributes to neuropathology covering glioma WHO 2021 classification, IDH and TERT promoter mutation testing, and intraoperative consultation for brain surgery.
Samsung Medical Center · VerifiedSujin Park
renal tumour pathology
Dr Sujin Park at SMC contributes to the histopathological and molecular characterisation of renal cell carcinoma subtypes, including the diagnosis of TFE3/TFEB rearrangement-associated RCC and SMARCB1-deficient renal medullary carcinoma.
Samsung Medical Center · VerifiedJae Won Oh
haematopathology
Dr Jae Won Oh contributes to haematopathology at SMC, covering the molecular workup of MDS including NGS-based gene panel testing for SF3B1, TET2, DNMT3A, and ASXL1 mutations correlated with bone marrow morphological classification.
Samsung Medical Center · VerifiedJihoon Oh
digital pathology
Dr Jihoon Oh at SMC contributes to digital pathology implementation and AI model validation for automated tumour grading and biomarker quantification in Korean clinical specimens.
Samsung Medical Center · VerifiedMi Ae Jang
molecular genetic pathology
Dr Mi Ae Jang at SMC contributes to hereditary cancer molecular testing, including NGS-based BRCA1/2 and Lynch syndrome MMR gene analysis for Korean cancer patients.
Samsung Medical Center · Verified